Cowen Financial Products LLC 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-01-18 4:28 pm Unchanged |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
0 (Unchanged) |
Filing |
| 2022-01-14 1:29 pm Sale |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 0 0.000% |
-2,015,513 (Position Closed) |
Filing |
| 2021-02-25 3:50 pm Purchase |
2021-02-22 | 13G | Celldex Therapeutics, Inc. CLDX |
Cowen Financial Products LLC | 2,015,513 5.094% |
2,015,513 (New Position) |
Filing |